Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:02:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added the topic keyword 'Amyloidosis' and updated the page revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T00:02:04.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor version update from v3.4.0 to v3.4.1; no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:53:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a Show glossary option and changes to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), with capitalization tweaks like 'No FEAR Act Data'. These are cosmetic changes that do not affect study content or eligibility information.
    Difference
    0.3%
    Check dated 2026-01-28T21:41:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 across the page. This appears to be a minor software revision with no changes to study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-01-14T04:24:45.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer updated: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:31:41.000Z thumbnail image

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.